Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Not yet recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22ulcerative+colitis.%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22
/vufind/Search/Results?lookfor=%22ulcerative+colitis.%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22
Search /vufind/Search2/Results?lookfor=%22ulcerative+colitis.%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22
PubPharm (2.830)
1
A Study to Evaluate the Safety and Efficacy of the Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative Colitis : A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis - UNIFI
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
BI 655130 induction treatment in patients with moderate-tosevere ulcerative colitis : A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of BI 655130 Induction Therapy in patients with moderate-to-severely active ulcerative colitis who have failed previous biologics therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Research study to determine whether an investigational drug, SHP647, is safe and effective in the treatment of moderate to severe Ulcerative Colitis, compared with placebo (dummy treatment) – using a randomised and blinded study design (investigator and patients are not aware whether they receive study drug or placebo)(FIGARO UC 303). : A Phase 3 Randomized, Double-blind, Placebo controlled, Parallel group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303) - FIGARO UC 303
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Study of efficacy, safety and tolerability of LYS006 in patients with mild to moderate ulcerative colitis : A randomized, multi-center, subject and investigator blinded, placebo controlled, parallel group study to assess the efficacy, safety and tolerability of LYS006 in patients with mild to moderate ulcerative colitis - NA
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A Multicenter, Randomized, Double-Blind Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in PediatricSubjects with Moderate to Severe Ulcerative Colitis. : A Multicenter, Randomized, Double-Blind Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in PediatricSubjects with Moderate to Severe Ulcerative Colitis.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A follow-up study in patients with moderate to severe active ulcerative colitis. : A follow-up Phase IIa study to evaluate the long-term safety and efficacy profile of ABX464given at 50 mg once daily in subjects with Moderate to Severe Active Ulcerative Colitis. - Follow-up study in Moderate to Severe Active Ulcerative Colitis subjects.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
BI 655130 induction treatment in patients with moderate-to severe ulcerative colitis : A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of BI 655130 Induction Therapy in patients with moderate-to-severely active ulcerative colitis who have failed previous biologics therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in PediatricSubjects with Moderate to Severe Ulcerative Colitis. : A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in PediatricSubjects with Moderate to Severe Ulcerative Colitis.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects with Moderate to Severe Ulcerative Colitis. : A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects with Moderate to Severe Ulcerative Colitis.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Ulcerative Colitis : A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[283]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Not yet recruiting
Medienart
2.830
Aufsätze
2.830
E-Artikel
2.830
E-Ressourcen
Zeitschriftentitel
2.802
WHO International Clinical Trials Registry Plat...
28
ClinicalTrials.gov
Thema
2.830
610
Recruitment Status: Not yet recruiting
2.703
Study Type: Interventional
899
Phase: Phase 3
749
Phase: Phase 2
132
Medical Condition: Ulcerative colitis MedDRA ve...
114
Medical Condition: Ulcerative Colitis MedDRA ve...
90
Study Type: Observational
78
Medical Condition: Ulcerative Colitis MedDRA ve...
74
Medical Condition: Ulcerative colitis
66
Medical Condition: Ulcerative Colitis MedDRA ve...
64
Medical Condition: Ulcerative Colitis
61
Phase: Phase 4
56
Medical Condition: ulcerative colitis
52
Medical Condition: Ulcerative Colitis (UC) MedD...
44
Medical Condition: Moderately to Severely Activ...
36
Medical Condition: Moderate to Severe Ulcerativ...
32
Medical Condition: Ulcerative Colitis MedDRA ve...
30
Medical Condition: Moderately to severely activ...
30
Medical Condition: Ulcerative Colitis MedDRA ve...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.350
2020-
1.480
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2.814
Englisch
10
Spanisch
4
Unbestimmt
2
Finnisch
Haven't found what you're looking for?
Wird geladen...